Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
DiaMedica Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Maximum Aggregate Offering Price |
Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee previously Paid In Connection with Unsold Securities to be Carried Forward |
Newly Registered Securities |
|||||||||
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
Carry Forward Securities |
|||||||||
Equity |
Voting Common Shares, no par value per share(1)(2) |
— |
(3)(4) |
(5) |
— |
— |
— |
— |
— |
Equity |
Warrants(2) |
— |
(3) |
(5) |
— |
— |
— |
— |
— |
Equity |
Units(6) |
— |
(3) |
(5) |
— |
— |
— |
— |
— |
Unallocated (Universal Shelf) |
— |
415(a)(6) |
(3)(4) |
$100,000,000.00 |
— |
S-3 |
333-254089 |
May 4, 2021 |
$10,910.00 |
Total Offering Amounts |
$100,000.00 |
$14,760.00 |
|||||||
Total Fees Previously Paid |
— |
||||||||
Total Fee Offsets |
$10,910.00 |
||||||||
Net Fee Due |
$3,850.00 |
(1) |
The aggregate amount of the registrant’s common shares registered hereunder is limited, solely for purposes of any at-the-market offerings, to that which is permissible under Rule 415(a)(4) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) |
Warrants will represent the right to purchase common shares. |
(3) |
An indeterminate amount of securities of each identified class is being registered as may from time to time be offered pursuant to this registration statement at indeterminate prices, along with an indeterminate number of common shares and other securities that may be issued upon exercise, settlement, exchange or conversion of, or pursuant to the anti-dilution provisions of, securities offered or sold hereunder. |
(4) |
Pursuant to Rule 416 under the Securities Act, the registrant’s common shares being registered hereunder include such indeterminate number of common shares as may be issuable by the registrant with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
(5) |
Not specified as to each class of securities to be registered hereunder pursuant to General Instruction II.D to Form S-3 under the Securities Act. Securities registered hereby may be sold separately or together with other securities registered hereby. Units may consist of two or more of the securities listed in “Table 1: Newly Registered and Carry Forward Securities” offered and sold together. |
(6) |
Units may consist of two or more of the securities listed in “Table 1: Newly Registered and Carry Forward Securities” offered and sold together. |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name |
Form or Filing Type |
File Number |
Initial Filing Date |
Filing Date |
Fee Offset Claimed |
Security Type Associated with Fee Offset Claimed |
Security Title Associated with Fee Offset Claimed |
Unsold Securities Associated with Fee Offset Claimed |
Unsold Aggregate Offering Amount Associated with Fee Offset Claimed |
Fee Paid with Fee Offset Source |
|
Rules 457(b) and 0-11(a)(2) |
|||||||||||
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
Rule 457(p) |
|||||||||||
Fee Offset Claims |
DiaMedica Therapeutics Inc. |
Form S-3 |
333-254089 |
March 10, 2021 |
— |
$10,910.00 (7) |
Equity |
Voting Common Shares, no par value per share |
(7) |
$10,910.00 |
— |
Fee Offset Sources |
DiaMedica Therapeutics Inc. |
Form S-3 |
333-254089 |
— |
March 10, 2021 |
— |
— |
— |
— |
— |
$10,910.00 |
(7) |
On March 10, 2021, the registrant filed a Registration Statement on Form S-3 (File No. 333-254089), which became effective on May 4, 2021 (the “Prior Registration Statement”). The Prior Registration Statement registered up to $100,000,000 in aggregate principal amount of common shares, warrants and units for sale by the registrant, which were not sold pursuant to the Prior Registration Statement. Pursuant to Rule 457(p) of the Securities Act, the registrant hereby offsets $10,910.00 of the $10,910.00 registration fee previously paid in connection with such unsold securities, which will continue to be applied to such unsold securities. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of such unsold securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. |